F-star Therapeutics Inc. (FSTX)
NASDAQ: FSTX
· Real-Time Price · USD
7.12
0.00 (0.00%)
At close: Mar 08, 2023, 10:00 PM
Revenue by Geography
| Period Ending | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|
| Other Revenue | 250K | 1.33M |
| Other Revenue Growth | -81.15% | n/a |
| Sweden Revenue | 500K | n/a |
| Sweden Revenue Growth | n/a | n/a |
| United States Revenue | 17.5M | n/a |
| United States Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 5.16M | 7.46M | 5.7M | 4.96M | 5.24M | 6.5M | 6.43M | 5.71M | 7.26M | 3.24M | 3.19M | 2.25M | 2.49M | 2.81M | 2.06M | 2.4M | 2.22M | 1.97M | 1.86M | 1.99M | 1.45M | 1.46M | 1.23M |
| Selling, General, and Administrative Revenue Growth | -30.79% | +30.78% | +14.91% | -5.29% | -19.41% | +1.12% | +12.63% | -21.39% | +124.38% | +1.47% | +41.92% | -9.76% | -11.39% | +36.47% | -14.17% | +7.92% | +12.96% | +6.03% | -6.59% | +36.85% | -0.41% | +18.92% | n/a |
| Research and Development Revenue | 9.67M | 8.72M | 8.04M | 8.21M | 5.11M | 8.44M | 7.27M | 3.43M | 5.32M | 2.09M | 3.4M | 5.23M | 7.28M | 5.57M | 5.66M | 5.55M | 3.98M | 3.22M | 3.4M | 2.53M | 2.72M | 2.94M | 5.59M |
| Research and Development Revenue Growth | +10.84% | +8.55% | -2.15% | +60.65% | -39.40% | +16.10% | +111.68% | -35.48% | +154.23% | -38.44% | -34.97% | -28.14% | +30.68% | -1.57% | +1.82% | +39.68% | +23.47% | -5.38% | +34.71% | -7.20% | -7.25% | -47.47% | n/a |